Feb 12, 2026 05:17PM
Jan 30, 2026 05:37AM
Jan 12, 2026 08:37AM
Dec 22, 2025 08:30AM
Dec 21, 2025 04:00AM
Dec 8, 2025 04:20AM
Dec 4, 2025 10:40AM CRISPR Therapeutics (CRSP) Ticks Higher on Takeover Speculation
Nov 17, 2025 11:13AM
Nov 17, 2025 10:59AM
Nov 11, 2025 04:45AM
Nov 11, 2025 04:24AM
Nov 11, 2025 04:13AM
Nov 11, 2025 04:03AM
Nov 10, 2025 03:25PM CRISPR Therapeutics (CRSP) PT Lowered to $50 at Clear Street
Nov 10, 2025 08:12AM
Nov 4, 2025 04:48PM
Oct 31, 2025 09:54AM
Oct 27, 2025 07:59AM
Oct 24, 2025 08:29AM
Oct 13, 2025 04:27AM
Oct 10, 2025 08:00AM CRISPR presents preclinical data for gene therapy targeting rare disorder
Sep 23, 2025 12:35PM
Sep 23, 2025 06:36AM
Sep 18, 2025 03:23AM
Aug 15, 2025 12:41PM
Aug 7, 2025 07:18AM
Aug 5, 2025 06:02AM
Aug 4, 2025 04:51PM CRISPR Therapeutics (CRSP) Misses Q2 EPS by 100c
Jun 27, 2025 10:58AM
Jun 27, 2025 06:49AM
Jun 27, 2025 04:40AM
Jun 26, 2025 04:15PM
Jun 26, 2025 02:08PM
Jun 26, 2025 11:00AM
Jun 26, 2025 10:34AM Chardan: 'We think CRSP's emergence as a credible player in the space could thus drive further valuation upside'
Jun 26, 2025 10:32AM
Jun 26, 2025 10:31AM
Jun 26, 2025 07:01AM
Jun 18, 2025 12:15PM
Jun 18, 2025 04:46AM
Jun 18, 2025 04:45AM
Jun 17, 2025 11:28AM Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
May 21, 2025 04:13AM
May 19, 2025 04:15PM
May 14, 2025 10:53AM
May 7, 2025 06:02AM
May 7, 2025 04:11AM
May 6, 2025 05:31PM
Apr 11, 2025 05:04AM Goldman Sachs Reiterates Neutral Rating on CRISPR Therapeutics (CRSP)
Apr 4, 2025 01:08PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All